For example, elevated lysophosphatidylcholine acyltransferase 1 (LPCAT1) levels are linked with poor prognosis and early tumor recurrence in breast cancer [258, 259], gastric and colorectal cancer [260, 261], prostate cancer [262, 263], ccRCC [264], liver cancer [265], and EGFR-dependent glioblastoma [266]. This evidence concerns the gene LPCAT1 and liver cancer.